See more : Pershing Square USA, Ltd. (PSUS) Income Statement Analysis – Financial Results
Complete financial analysis of Vext Science, Inc. (VEXT.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vext Science, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Qingdao Baheal Medical INC. (301015.SZ) Income Statement Analysis – Financial Results
- Associated British Foods plc (ASBFF) Income Statement Analysis – Financial Results
- SHAMROCK INDUSTRIAL CO.LTD. (SHAMROIN.BO) Income Statement Analysis – Financial Results
- Catenai PLC (CTAI.L) Income Statement Analysis – Financial Results
- PLANISWARE PROMESSES (PLNW.PA) Income Statement Analysis – Financial Results
Vext Science, Inc. (VEXT.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.vextscience.com
About Vext Science, Inc.
Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. The company is involved in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. It also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen and Pure Touch Botanicals brands. In addition, the company offers Vapen clear infused products, THC chocolate bars, THC syrup, THC snacks, candies, and gummies under Vapen Kitchens brand. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona .
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 34.81M | 35.41M | 37.24M | 25.19M | 22.32M | 18.48M | 14.85M |
| Cost of Revenue | 22.77M | 12.31M | 18.56M | 13.99M | 12.26M | 8.82M | 6.22M |
| Gross Profit | 12.04M | 23.10M | 18.69M | 11.20M | 10.07M | 9.65M | 8.63M |
| Gross Profit Ratio | 34.58% | 65.23% | 50.17% | 44.45% | 45.09% | 52.26% | 58.14% |
| Research & Development | 0.00 | 0.00 | 150.06K | 158.69K | 112.96K | 107.35K | 70.77K |
| General & Administrative | 8.33M | 9.82M | 5.28M | 4.66M | 4.29M | 823.81K | 827.32K |
| Selling & Marketing | 5.51M | 0.00 | 487.03K | 443.98K | 926.46K | 1.02M | 437.01K |
| SG&A | 13.84M | 9.82M | 5.77M | 5.10M | 5.21M | 2.84M | 2.17M |
| Other Expenses | -1.80M | 3.99M | 3.55M | 2.58M | 1.16M | 0.00 | 0.00 |
| Operating Expenses | 12.04M | 13.82M | 9.47M | 7.84M | 6.48M | 4.03M | 2.91M |
| Cost & Expenses | 36.61M | 26.13M | 28.03M | 21.83M | 18.74M | 12.85M | 9.13M |
| Interest Income | 176.24K | 111.99K | 739.49K | 378.95K | 8.10K | 0.00 | 0.00 |
| Interest Expense | 3.81M | 2.05M | 2.23M | 745.02K | 64.59K | 59.37K | 84.79K |
| Depreciation & Amortization | 9.59M | 6.18M | 3.26M | 2.25M | 852.62K | 537.91K | 414.18K |
| EBITDA | 16.77M | 15.03M | 12.80M | 5.52M | 4.67M | 5.58M | 6.13M |
| EBITDA Ratio | 48.17% | 43.39% | 34.30% | 21.25% | 19.82% | 30.21% | 37.95% |
| Operating Income | -1.80M | 8.93M | 9.49M | 3.22M | 3.59M | 5.58M | 5.64M |
| Operating Income Ratio | -5.18% | 25.22% | 25.47% | 12.77% | 16.09% | 30.21% | 37.95% |
| Total Other Income/Expenses | 5.16M | -6.58M | -3.43M | -719.99K | 85.53K | -462.32K | -84.79K |
| Income Before Tax | 3.36M | 6.70M | 6.82M | 2.64M | 3.67M | 4.88M | 5.64M |
| Income Before Tax Ratio | 9.66% | 18.91% | 18.31% | 10.48% | 16.43% | 26.41% | 37.95% |
| Income Tax Expense | -1.04M | -4.22M | 1.83M | 514.00K | 874.91K | 1.13M | 1.53M |
| Net Income | 4.40M | 10.92M | 4.99M | 2.13M | 2.79M | 3.75M | 4.11M |
| Net Income Ratio | 12.63% | 30.84% | 13.39% | 8.43% | 12.51% | 20.29% | 27.66% |
| EPS | 0.03 | 0.08 | 0.04 | 0.02 | 0.03 | 0.05 | 0.06 |
| EPS Diluted | 0.03 | 0.08 | 0.03 | 0.02 | 0.03 | 0.05 | 0.06 |
| Weighted Avg Shares Out | 164.48M | 138.85M | 136.71M | 92.77M | 84.36M | 81.20M | 65.13M |
| Weighted Avg Shares Out (Dil) | 164.74M | 139.53M | 146.41M | 93.53M | 84.36M | 81.20M | 65.13M |
Source: https://incomestatements.info
Category: Stock Reports